Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
PLoS One. 2020 Mar 30;15(3):e0230707. doi: 10.1371/journal.pone.0230707. eCollection 2020.
People living with HIV who are on antiretroviral treatment are at increased risk of developing premature cardiovascular disease. Children with perinatal HIV infection (PHIV) have survived through their adolescence and are entering adulthood. We determined the prevalence of metabolic syndrome, abnormal biochemical markers, and characterized body composition parameters in youth living with perinatal HIV infection. This cross-sectional study was conducted at the Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand from December 2017 to February 2018. PHIV-youths between 15 <25 years of age who were receiving ART were enrolled. Data collection included ART-related history, blood pressure, and anthropometric measurements. Body composition including android, gynoid fat mass, and total body fat were measured by dual-energy X-ray absorptiometry. Fasting blood was drawn to test for lipid profile, glucose, and high sensitivity c-reactive protein (hsCRP). One hundred and twenty PHIV-youths (48% female) were enrolled. Their mean age and the median duration on ART were 20.3 (SD2.6) and 14.1 (IQR 10.4-14.9) years, respectively; 76 (63%) were on first-line non-nucleoside reverse transcriptase inhibitors-based regimens. Thirty-three (28%), 74 (62%), and 13 (11%) of PHIV-youths were underweight (BMI < 18.5 kg/m2), normal (BMI 18.5-24.9 kg/m2), and overweight (BMI ≥ 25.0 kg/m2), respectively. The prevalence of metabolic syndrome was 10.6% (95%CI 5.0-16.0). Seventy-six of 113 (67.3%) of PHIV-youths had lipid alteration; the most prevalent types being low HDL (46.9%) and increased triglycerides (27.4%). Overall 43 (35.9%) had increased hsCRP (16.7% with immediate and 19.2% with high risk for CVD). Females had significantly higher percentage of android and gynoid fat, but lower Android to gynoid ratio (AGR) compared to males. There were 77%, 31%, and 21% of PHIV-youths in the overweight, normal weight, and underweight group with AGR in tertile 3, respectively. In conclusion, we documented presence of metabolic syndrome in 10.6% of PHIV-youths on ART. Increase AGR representing abdominal obesity was detected even in youths with normal BMI or underweight.
感染人类免疫缺陷病毒(HIV)并接受抗逆转录病毒治疗的人群发生心血管疾病的风险增加。围生期感染 HIV(PHIV)的儿童已经度过青春期并进入成年期。我们确定了围生期 HIV 感染青年中代谢综合征、生化标志物异常和身体成分参数的流行情况。本横断面研究于 2017 年 12 月至 2018 年 2 月在泰国清迈大学健康科学研究所进行。招募了年龄在 15-25 岁之间接受抗逆转录病毒治疗的 PHIV 青年。数据收集包括抗逆转录病毒治疗相关史、血压和人体测量。通过双能 X 射线吸收法测量身体成分,包括安卓、女性脂肪量和全身脂肪量。空腹采血检测血脂、血糖和高敏 C 反应蛋白(hsCRP)。共纳入 120 名 PHIV 青年(48%为女性)。他们的平均年龄和抗逆转录病毒治疗的中位数时间分别为 20.3(SD2.6)和 14.1(IQR10.4-14.9)年;76 人(63%)正在服用一线非核苷类逆转录酶抑制剂为基础的方案。33 人(28%)、74 人(62%)和 13 人(11%)的 PHIV 青年体重过轻(BMI<18.5kg/m2)、正常(BMI18.5-24.9kg/m2)和超重(BMI≥25.0kg/m2)。代谢综合征的患病率为 10.6%(95%CI5.0-16.0)。113 名 PHIV 青年中有 76 名(67.3%)血脂异常;最常见的类型是低高密度脂蛋白(46.9%)和甘油三酯升高(27.4%)。共有 43 名(35.9%)hsCRP 升高(16.7%有即刻风险,19.2%有 CVD 高风险)。女性的安卓和女性脂肪百分比明显高于男性,但安卓与女性脂肪比例(AGR)较低。超重、正常体重和体重不足组分别有 77%、31%和 21%的 PHIV 青年 AGR 处于三分位数 3 中。总之,我们发现接受抗逆转录病毒治疗的 PHIV 青年中有 10.6%患有代谢综合征。即使在 BMI 正常或体重不足的青少年中,也检测到了代表腹部肥胖的 AGR 增加。